Earnings call transcript: Ampco-Pittsburgh Q1 2026 results disappoint

Ampco-Pittsburgh reported Q1 2026 net sales of $108.3 million, up 3.9% year over year, but adjusted EBITDA fell to $8.0 million from $8.8 million and EPS missed at -$0.04, triggering a 14.76% early trading drop. Air & Liquid Processing set record orders and EBITDA, while Forged and Cast Engineered Products was weighed down by timing issues, tariff-related order deferrals, and higher-cost inventory. Management said liquidity remains solid at $40 million and expects $7 million-$8 million of annual EBITDA improvement going forward, with debt reduction of roughly $8 million-$10 million targeted this year.

Analysis

The market is reacting to a headline miss, but the more important signal is the split between a fast-improving growth engine and a legacy business that is still digesting prior inefficiencies. That dynamic usually creates a near-term valuation trap: the multiple compresses on consolidated earnings weakness even as the mix shift into a higher-quality segment lifts the mid-cycle earnings power over the next 2-3 quarters. The key second-order effect is that liquidity plus easier working capital from a stronger order book could convert this from a “survival” story into a balance-sheet repair story by year-end.

The tariff backdrop matters more than the reported quarter. For the forged business, the removal of trade uncertainty should release deferred orders, but it also reduces the chance of a speculative squeeze in the share price because the improvement is now becoming visible rather than latent. Competitively, the exit of smaller roll manufacturers should improve pricing discipline in a fragmented market; that’s a slow-burn benefit that typically shows up with a 1-2 quarter lag as customers re-source and incumbents reclaim share.

The risk is that investors are underestimating how much of the year’s upside is already in the book after a massive six-month rerating. If execution slips on the new capacity build, or if working-capital needs consume cash faster than expected, the equity can re-rate down sharply because the stock still behaves like a levered cyclical rather than a compounder. The cleaner catalyst path is a visible sequential margin recovery in forged/cast plus a continued order backlog build in air/liquid systems; absent that, the move looks overextended on a 6-12 month horizon.

Consensus is likely over-focused on the EPS miss and underweighting the asymmetry from improved mix and industry consolidation. The contrarian read is that the current drawdown may be an opportunity to buy the earnings inflection, but only if you’re willing to wait through a noisy next print or two. This is a story where the stock can stay cheap for the wrong reason until management proves cash generation, not just orders.

Key Decisions for Investors

• Long AP on weakness for a 2-4 quarter trade; target a move back toward pre-earnings levels if sequential margin recovery is confirmed. Risk is a failed turnaround in forged/cast or working-capital pressure.
• Use a call spread rather than outright equity: buy AP 3-6 month calls and sell a higher strike to express recovery with defined downside. This fits a catalyst window where order-book normalization should show up before year-end.
• Pair trade: long AP vs short a more indebted industrial cyclical with less visible backlog quality. The relative value thesis is that AP’s liquidity and segment mix improve faster than the market is pricing.
• If already long, hedge with tight stop discipline around the post-earnings gap; the stock’s prior rerating makes it vulnerable to a 15-20% air pocket on any execution disappointment.
• Avoid chasing immediately; wait for the next management update or evidence of sequential cash conversion. The best entry is likely after the market gets confirmation that the quoted timing issues are reversing, not before.